title: Changes of epidermal cell morphology and keratin expression induced by inhibitors of protein kinase C.
abstract: Several lines of evidence show protein kinase C as being involved in various regulatory processes in keratinocyte biology, e.g. proliferation and differentiation. In the present study, we investigated the effects of three different inhibitors of protein kinase C, staurosporine, CP 46'665-1, and tiflucarbine, on cell morphology and keratin expression in a non-tumorigenic human keratinocyte cell line (HaCaT cells). Staurosporine, being the most potent inhibitor of protein kinase C activity in vitro, and CP 46'665-1 induced morphological transformation to a fibroblast-like cell shape. In contrast, no changes in cell morphology were observed after exposure to tiflucarbine. The investigation of keratin expression in HaCaT cells grown in the presence of the different compounds revealed the following changes: After 72 h of cultivation, keratins 8 and 18 were still expressed in treated cells, whereas expression of keratin 13 was decreased as compared to control cells. Immunoblotting to detect vimentin demonstrated its absence in treated and control cells. Since tiflucarbine is known as a dual protein kinase C/calmodulin inhibitor whereas staurosporine and CP 46'665-1 do not antagonize calmodulin function, it might be possible that not only protein kinase C but also calmodulin is involved in the process leading to the morphological changes.
authors.affiliation: Department of Dermatology, University of Köln, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Hegemann
authors.forename: A
authors.initials: A
authors.lastname: Wevers
authors.forename: B
authors.initials: B
authors.lastname: Bonnekoh
authors.forename: G
authors.initials: G
authors.lastname: Mahrle
mesh_terms: D000470:Alkaloids / Q000494:pharmacology; D002147:Calmodulin / Q000037:antagonists & inhibitors; D002460:Cell Line; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D007633:Keratins / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D019311:Staurosporine; D013876:Thiophenes / Q000494:pharmacology
chemical_list: D000470:Alkaloids; D002147:Calmodulin; D007211:Indoles; D010880:Piperidines; D013876:Thiophenes; D007633:Keratins; C038408:CP 46665; D011493:Protein Kinase C; D019311:Staurosporine; C050288:tiflucarbine